Analysis of infection-related adverse events induced by proton pump inhibitors based on the FAERS and JADER databases. [PDF]
Hu S, Yu H, Liu Z.
europepmc +1 more source
Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials [PDF]
core +1 more source
Clinical Outcomes and Real-World Effectiveness of Amoxicillin-Clavulanic Acid Across Indian Healthcare Settings: A Retrospective Multicenter Study. [PDF]
Raju A +5 more
europepmc +1 more source
Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. [PDF]
Dertli R +6 more
europepmc +1 more source
Nonclinical and Clinical Assessments of an Optimized Tablet Formulation of the Novel HER2-Selective Tyrosine Kinase Inhibitor Zongertinib: Focus on Relative Bioavailability and Impact of Variation of Gastric pH. [PDF]
Wölke S +8 more
europepmc +1 more source
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection [PDF]
core +1 more source
Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. [PDF]
Kim S, Kim JS.
europepmc +1 more source
Adjunctive probiotic therapy sustains symptom relief in gastroesophageal reflux disease through gut microbiome-metabolome remodeling. [PDF]
Li Y +16 more
europepmc +1 more source
Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan. [PDF]
Takami A +4 more
europepmc +1 more source

